MedTrace Logo

Assessment of Sulphadoxine-pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Malawi

NCT01120145 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1410

Last updated 2013-02-06

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy and effectiveness of sulphadoxine-pyrimethamine intermittent preventive treatment in pregnancy for reducing malaria-associated morbidity in pregnant women in Malawi.

Conditions

  • Malaria in Pregnancy

Sponsors & Collaborators

Principal Investigators

  • Jacek Skarbinski, MD · Malaria Branch, Centers for Disease Control and Prevention

  • Don Mathanga, MD, PhD · Kamuzu University of Health Sciences

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • Malawi

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01120145 on ClinicalTrials.gov